B-Cell Depletion Helps Maintain Kidney Function in Lupus Nephritis
(MedPage Today) -- SAN DIEGO -- Treatment with the B-cell depleting agent obinutuzumab (Gazyva) helped patients with lupus nephritis avoid the most serious adverse outcomes, according to a post hoc analysis of randomized trial data.
Among 125... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 10, 2023 Category: Rheumatology Source Type: news
Obinutuzumab Promotes Renal Preservation in Lupus Nephritis Obinutuzumab Promotes Renal Preservation in Lupus Nephritis
A post hoc analysis of the NOBILITY trial showed improved outcomes for patients taking obinutuzumab (Gazyva) compared with placebo.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 10, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Antiphospholipid Antibodies Vary by Race in People With SLE Antiphospholipid Antibodies Vary by Race in People With SLE
A study of multiple cohorts of patients with systemic lupus erythematosus showed significantly lower prevalence of antiphospholipid antibodies (aPLs) among Black patients.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 2, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Major Source of Lupus Morbidity More Common in Certain Racial-Ethnic Groups
(MedPage Today) -- Among patients with systemic lupus erythematosus (SLE), high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found.
Rates for most... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 25, 2023 Category: American Health Source Type: news
Nkarta stock soars 112% after FDA clears cell therapy to go beyond cancer into lupus
Nkarta wants cell therapy to go beyond cancer and has been given the FDA green light to move forward with a CAR NK candidate in human trials for lupus—news that sent the company’s stock soaring 112%. “Autoimmune patients have limited options these days, and those options that they have are often…#nkarta #fda #autoimmune #paulhastings #fiercebiotech #nkx019 #davidshook #fierce #sle #shook (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2023 Category: Consumer Health News Source Type: news
Peninsula biotech's stock soars as it cuts staff, focuses cell therapy on autoimmune diseases
The company's stock finished Tuesday 110% higher after it outlined plans to cut staff by 10%, extend its cash runway and focus on diseases like lupus. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 17, 2023 Category: Biotechnology Authors: Ron Leuty Source Type: news
Tapering Lupus Drugs in Stable Patients: Flare Risks Studied Tapering Lupus Drugs in Stable Patients: Flare Risks Studied
Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 3, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Are Cellular Therapies the Future of Autoimmune Disease? Are Cellular Therapies the Future of Autoimmune Disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR-T cell therapy to treat -- and possibly cure -- autoimmune diseases like lupus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Ginger May Ease Inflammation of Autoimmune Diseases
MONDAY, Sept. 25, 2023 -- Ginger supplements may help those with certain autoimmune diseases, such as lupus and rheumatoid arthritis, control inflammation.
New research has added evidence to support the impact of ginger on white blood cell function,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 25, 2023 Category: General Medicine Source Type: news
Lupus May Overlap in Many Patients With Systemic Sclerosis Lupus May Overlap in Many Patients With Systemic Sclerosis
Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) showed a distinct clinical phenotype from those with SSc alone, but mortality was similar.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
HCQ Blood Level'Sweet Spot' May Maximize Efficacy in Lupus HCQ Blood Level'Sweet Spot' May Maximize Efficacy in Lupus
Researchers identified a blood-level reference range linked with 71% lower odds of active lupus.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 12, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Rheum Patients on HCQ: Stick With It or Face Heart Consequences
(MedPage Today) -- High levels of adherence to prescribed antimalarial drugs for lupus and rheumatoid arthritis (RA) was associated with markedly lower cardiovascular event rates in one Canadian province, researchers found.
Rates for a composite... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 11, 2023 Category: Rheumatology Source Type: news
Study Finds Link Between Asbestos Exposure and Autoimmune Conditions
Asbestos is widely known as an occupational hazard, but emerging evidence suggests that prolonged exposure to environmental asbestos could lead to severe autoimmune conditions, according to a study by Montana State University researchers.
Microbiology and immunology research associate Dr. Jean Pfau and a team of researchers discovered the connection to a specific type of asbestos found near the once badly contaminated town of Libby, Montana, and a novel autoimmune disease. The autoimmune condition is associated with collagen thickening of the serum-producing membranes surrounding the lungs.
Pfau, chairperson for the ...
Source: Asbestos and Mesothelioma News - August 31, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Clinical Trials/Research/Emerging Treatments Source Type: news
Racial Discrimination Linked to Increased CRP in Black Women With Lupus
MONDAY, Aug. 14, 2023 -- For Black women with systemic lupus erythematosus (SLE), incident racial discrimination is associated with elevated C-reactive protein (CRP), according to a study published in the August issue of Brain, Behavior, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2023 Category: Pharmaceuticals Source Type: news
Headaches With Lupus Are Common. Are They Actually Migraine?
More than half of Americans with the most common form of lupus regularly get headaches. New research now shows that these often are not just normal headaches. (Source: WebMD Health)
Source: WebMD Health - August 4, 2023 Category: Consumer Health News Source Type: news
